Order Article Reprints

Delwar Z, Tatsiy O, Chouljenko DV, Lee I-F, Liu G, Liu X, Bu L, Ding J, Singh M, Murad YM, et al. Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells. Vaccines. 2023; 11(12):1805. https://doi.org/10.3390/vaccines11121805

Delwar, Zahid, Olga Tatsiy, Dmitry V. Chouljenko, I-Fang Lee, Guoyu Liu, Xiaohu Liu, Luke Bu, Jun Ding, Manu Singh, Yanal M. Murad, and et al. 2023. "Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells" Vaccines 11, no. 12: 1805. https://doi.org/10.3390/vaccines11121805

Delwar, Z., Tatsiy, O., Chouljenko, D. V., Lee, I.-F., Liu, G., Liu, X., Bu, L., Ding, J., Singh, M., Murad, Y. M., & Jia, W. W.-G. (2023). Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells. Vaccines, 11(12), 1805. https://doi.org/10.3390/vaccines11121805